000 01045 a2200289 4500
005 20250515222107.0
264 0 _c20100602
008 201006s 0 0 eng d
022 _a1465-3249
024 7 _a10.1080/0032472031000141278
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRobinowitz, M
245 0 0 _aFDA's new regulatory paradigms for in vitro diagnostic devices.
_h[electronic resource]
260 _bCytotherapy
_c1999
300 _a353-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aDevice Approval
_xlegislation & jurisprudence
650 0 4 _aEquipment and Supplies
_xstandards
650 0 4 _aGovernment Regulation
650 0 4 _aHumans
650 0 4 _aReagent Kits, Diagnostic
_xstandards
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
_xorganization & administration
700 1 _aGutman, S I
773 0 _tCytotherapy
_gvol. 1
_gno. 4
_gp. 353-7
856 4 0 _uhttps://doi.org/10.1080/0032472031000141278
_zAvailable from publisher's website
999 _c19783407
_d19783407